Shares of Carisma Therapeutics Inc. (CARM) have been struggling lately and have lost 12.1% over the past week. However, a hammer chart pattern was formed in its last trading session, which could mean ...

Carisma Therapeutics Inc. (CARM) could be a solid choice for investors given its recent upgrade to a Zacks Rank #2 (Buy). This upgrade is essentially a reflection of an upward trend in earnings ...

CJ Camerieri already has an extensive resume: he’s a horn player, founder of the contemporary classical group yMusic, and has played with Bon Iver, Paul Simon, Sufjan Stevens, and the National.

Carisma Therapeutics (NASDAQ:CARM) climbed ~29% premarket Friday after the cell therapy developer said it would receive $2M for discovering a cancer drug candidate as part of a collaboration with ...

CARISMA THERAPEUTICS ($CARM) is expected to release its quarterly earnings data on Tuesday, April 8th after market close, per Finnhub. Analysts are expecting revenue ...

CJ Camerieri of yMusic and Sufjan Stevens have teamed up for new single, “Song of Trouble.” The track appears on upcoming LP CARM, Camerieri’s solo debut album that’s named after the moniker he ...